Product Information |
BR-1397_PI_01.pdf
|
Registration Number |
BR-1397
|
Generic Name |
Brolucizumab
|
Brand Name |
Vsiqq
|
Dosage Strength |
120 mg/mL (27.6 mg/0.23 mL)
|
Dosage Form |
Solution for Injection (Intravitreal)
|
Classification |
Prescription Drug (RX)
|
Packaging |
Single use. 0.23 mL in 2 mL Ph. Eur. Type I
colourless glass vial with grey rubber stopper and an aluminum seal with violet flip-off cap + 1 12" 18G filter needle in a soft blister (Box of l's)
|
Pharmacologic Category |
Antineovascularization Agent
|
Manufacturer |
Novartis Pharma Stein AG Technical Operations
|
Country of Origin |
Switzerland
|
Trader |
|
Importer |
Novartis Healthcare Philippines, Inc.
|
Distributor |
|
Application Type |
Monitored Release (MR)
|
Issuance Date |
01 April 2022
|
Expiry Date |
01 April 2027
|